The regulator granted the application priority review for this indication, assigning a Prescription Drug User Fee Act (PDUFA) date of 30 September 2026.
pharminent
June 2, 2026 (Last updated: June 4, 2026)
Pharmaceutical Business Review
The regulator granted the application priority review for this indication, assigning a Prescription Drug User Fee Act (PDUFA) date of 30 September 2026.
